FDA Picks Nine Drugs for Fast-Track Reviews in New Program

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Rachel Cohrs Zhang and Gerry Smith

October 16, 2025 at 11:02 PM UTC

Updated on

October 17, 2025 at 11:50 AM UTC

The US Food and Drug Administration on Thursday announced the first drug manufacturers that will receive expedited reviews as part of a new initiative to reward companies for acquiescing to the Trump administration’s stated policy priorities.

During a press conference, FDA Commissioner Marty Makary said that nine drugs have been chosen for priority vouchers.